Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Iyer

Showing results (191-200 of 308) with videos related to

Pageof 31
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioateJohn E Coughlin, Rajendra K Pandey, Seetharamaiyer Padmanabhan, et al.
Leukemia|March 22, 2017
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cellsW Fiskus, S Sharma, B Shah, et al.
Leukemia|July 8, 2015
HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonistS G T Devaraj, W Fiskus, B Shah, et al.
Journal of Molecular and Cellular Cardiology|January 25, 2020
Age- and sex-dependent differences in extracellular matrix metabolism associate with cardiac functional and structural changesGabriel A Grilo, Patti R Shaver, Hamilton J Stoffel, et al.
Leukemia|April 5, 2014
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cellsW Fiskus, S Sharma, B Shah, et al.
British Journal of Haematology|August 21, 2014
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related eventsSwaminathan P Iyer, Joseph Taddeus Beck, A Keith Stewart, et al.
Biochemical and Biophysical Research Communications|August 22, 2020
Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosisGabriel Gaweda, Rugmani P Iyer, Patti R Shaver, et al.
JAAD Case Reports|October 25, 2021
Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapseChristopher N Nguyen, Swaminathan P Iyer, Roberto N Miranda, et al.
Annals of the American Thoracic Society|October 2, 2018
Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-AnalysisNarayan P Iyer, Chakravarthy B Reddy, Momen M Wahidi, et al.
Iscience|June 12, 2018
SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break RepairSharmistha Chakraborty, Raj K Pandita, Shashank Hambarde, et al.
Pageof 31

Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioateJohn E Coughlin, Rajendra K Pandey, Seetharamaiyer Padmanabhan, et al.
Leukemia|March 22, 2017
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cellsW Fiskus, S Sharma, B Shah, et al.
Leukemia|July 8, 2015
HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonistS G T Devaraj, W Fiskus, B Shah, et al.
Journal of Molecular and Cellular Cardiology|January 25, 2020
Age- and sex-dependent differences in extracellular matrix metabolism associate with cardiac functional and structural changesGabriel A Grilo, Patti R Shaver, Hamilton J Stoffel, et al.
Leukemia|April 5, 2014
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cellsW Fiskus, S Sharma, B Shah, et al.
British Journal of Haematology|August 21, 2014
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related eventsSwaminathan P Iyer, Joseph Taddeus Beck, A Keith Stewart, et al.
Biochemical and Biophysical Research Communications|August 22, 2020
Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosisGabriel Gaweda, Rugmani P Iyer, Patti R Shaver, et al.
JAAD Case Reports|October 25, 2021
Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapseChristopher N Nguyen, Swaminathan P Iyer, Roberto N Miranda, et al.
Annals of the American Thoracic Society|October 2, 2018
Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-AnalysisNarayan P Iyer, Chakravarthy B Reddy, Momen M Wahidi, et al.
Iscience|June 12, 2018
SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break RepairSharmistha Chakraborty, Raj K Pandita, Shashank Hambarde, et al.
Pageof 31